Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 14, 2022
Pulmonary
fibrosis
is
a
progressive
and
intractable
lung
disease
with
fibrotic
features
that
affects
alveoli
elasticity,
which
leading
to
higher
rates
of
hospitalization
mortality
worldwide.
initiated
by
repetitive
localized
micro-damages
the
alveolar
epithelium,
subsequently
triggers
aberrant
epithelial-fibroblast
communication
myofibroblasts
production
in
extracellular
matrix,
resulting
massive
matrix
accumulation
interstitial
remodeling.
The
major
cell
types
responsible
for
pulmonary
are
myofibroblasts,
epithelial
cells,
macrophages,
endothelial
cells.
Recent
studies
have
demonstrated
metabolic
reprogramming
or
dysregulation
these
cells
exerts
their
profibrotic
role
via
affecting
pathological
mechanisms
such
as
autophagy,
apoptosis,
aging,
inflammatory
responses,
ultimately
contributes
development
fibrosis.
This
review
summarizes
recent
findings
on
occur
aforementioned
during
fibrosis,
especially
those
associated
glucose,
lipid,
amino
acid
metabolism,
aim
identifying
novel
treatment
targets
Genes and Immunity,
Journal Year:
2021,
Volume and Issue:
22(3), P. 141 - 160
Published: June 17, 2021
When
surveying
the
current
literature
on
COVID-19,
"cytokine
storm"
is
considered
to
be
pathogenetically
involved
in
its
severe
outcomes
such
as
acute
respiratory
distress
syndrome,
systemic
inflammatory
response
and
eventually
multiple
organ
failure.
In
this
review,
similar
role
of
DAMPs
addressed,
that
is,
those
molecules,
which
operate
upstream
pathway
by
activating
cells,
ultimately
release
cytokines.
Given
still
limited
reports
their
emerging
topic
extended
viral
infections
with
focus
influenza.
At
first,
a
brief
introduction
given
function
various
classes
counterbalancing
suppressing
(SAMPs)
initiating
controlled
inflammation-promoting
inflammation-resolving
defense
responses
upon
infectious
sterile
insults.
It
stressed
excessive
emission
injury
uncovers
fateful
property
triggering
dysregulated
life-threatening
hyperinflammatory
responses.
Such
scenario
may
happen
when
load
too
high,
for
example,
tract,
"forcing"
many
virus-infected
host
cells
decide
commit
"suicidal"
regulated
cell
death
(e.g.,
necroptosis,
pyroptosis)
associated
large
amounts
DAMPs:
an
important
review.
Ironically,
although
aim
save
restore
organismal
homeostasis,
intrinsic
leads
responses—as
typically
pathogenesis
syndrome
infections.
Consequently,
briefly
outlined
these
molecules
can
valuable
diagnostic
prognostic
biomarkers
monitor
evaluate
course
disorder,
particular,
grasp
eventual
transition
precociously
from
observed
mild/moderate
cases
seen,
severe/fatal
COVID-19.
Moreover,
pathogenetic
involvement
qualifies
them
relevant
future
therapeutic
targets
prevent
severe/
fatal
outcomes.
Finally,
theory
presented
proposing
superimposition
coronavirus-induced
non-virus-induced
other
origins
air
pollution
or
high
age
contribute
courses
coronavirus
pneumonia.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(6), P. 1704 - 1704
Published: March 19, 2022
The
latest
guidelines
for
the
hospital
care
of
patients
affected
by
coronavirus
disease
2019
(COVID-19)-related
acute
respiratory
failure
have
moved
towards
widely
accepted
use
noninvasive
support
(NIRS)
as
opposed
to
early
intubation
at
pandemic
onset.
establishment
severe
COVID-19
pneumonia
goes
through
different
pathophysiological
phases
that
partially
resemble
typical
distress
syndrome
(ARDS)
and
been
categorized
into
clinical–radiological
phenotypes.
These
can
variably
benefit
on
application
external
positive
end-expiratory
pressure
(PEEP)
during
mechanical
ventilation,
mainly
due
variable
levels
lung
recruitment
ability
compliance
disease.
A
growing
body
evidence
suggests
intense
effort
producing
excessive
negative
pleural
swings
(Ppl)
plays
a
critical
role
in
onset
progression
diaphragm
damage
treated
with
support.
Routine
monitoring
is
mandatory
avoid
nasty
continuation
NIRS
who
are
higher
risk
deterioration
could
from
initiation
invasive
ventilation
instead.
Here
we
propose
methods
both
clinical
experimental
settings
adapted
this
purpose,
although
further
research
required
allow
their
extensive
practice.
We
reviewed
needs
available
tools
clinical–physiological
aims
optimizing
ventilatory
management
coronavirus-2
(SARS-CoV-2)
infection.
Frontiers in Medicine,
Journal Year:
2023,
Volume and Issue:
10
Published: Nov. 21, 2023
Sepsis
is
a
systemic
inflammatory
disease
caused
by
severe
infections
that
involves
multiple
organs,
among
which
the
lung
most
susceptible,
leaving
patients
highly
vulnerable
to
acute
injury
(ALI).
Refractory
hypoxemia
and
respiratory
distress
are
classic
clinical
symptoms
of
ALI
sepsis,
has
mortality
rate
40%.
Despite
extensive
research
on
mechanisms
exact
pathological
process
not
fully
understood.
This
article
reviews
advances
in
pathogenesis
sepsis
focusing
treatment
regimens
adopted
practice
for
corresponding
molecular
mechanisms.
review
can
only
contribute
theories
but
also
recommend
new
strategies
related
injuries.
Mediators of Inflammation,
Journal Year:
2023,
Volume and Issue:
2023, P. 1 - 15
Published: July 6, 2023
Most
patients
diagnosed
with
chronic
obstructive
pulmonary
disease
(COPD)
present
hallmark
features
of
airway
mucus
hypersecretion,
including
cough
and
expectoration.
Airway
function
as
a
native
immune
system
the
lung
that
severs
to
trap
particulate
matter
pathogens
allows
them
clear
from
via
ciliary
transport.
Chronic
hypersecretion
(CMH)
is
main
factor
contributing
increased
risk
morbidity
mortality
in
specific
subsets
COPD
patients.
It
is,
therefore,
primarily
important
develop
medications
suppress
hypersecretions
these
Although
there
have
been
some
advances
treatment,
more
work
remains
be
done
better
understand
mechanism
underlying
seek
effective
treatments.
This
review
article
discusses
structure
significance
lungs
focusing
on
gel-forming
mucins
impacts
CMH
lungs.
Furthermore,
we
summarize
pharmacological
nonpharmacological
treatments
well
novel
interventional
procedures
control
Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: March 9, 2024
Abstract
Pulmonary
fibrosis
(PF)
is
a
progressive
interstitial
inflammatory
disease
with
high
mortality
rate.
Patients
PF
commonly
experience
chronic
dry
cough
and
dyspnoea
for
years
without
effective
mitigation.
The
pathogenesis
of
believed
to
be
associated
dysfunctional
macrophage
polarization,
fibroblast
proliferation,
the
loss
epithelial
cells.
Thus,
it
great
importance
necessity
explore
interactions
among
macrophages,
fibroblasts,
alveolar
cells
in
lung
fibrosis,
as
well
pro-fibrotic
microenvironment.
In
this
review,
we
discuss
latest
studies
that
have
investigated
polarization
activation
non-immune
context
progression.
Next,
how
profibrotic
cellular
crosstalk
promoted
microenvironment
by
multiple
cytokines,
chemokines,
signalling
pathways.
And
finally,
potential
mechanisms
fibrogenesis
development
efficient
therapeutic
strategies
disease.
Herein,
provide
comprehensive
summary
vital
role
its
fibroblasts
suggest
treatment
target
their
communication
The FASEB Journal,
Journal Year:
2024,
Volume and Issue:
38(8)
Published: April 22, 2024
Considerable
progress
has
been
made
in
understanding
the
function
of
alveolar
epithelial
cells
a
quiescent
state
and
regeneration
mechanism
after
lung
injury.
Lung
injury
occurs
commonly
from
severe
viral
bacterial
infections,
inhalation
injury,
indirect
sepsis.
A
series
pathological
mechanisms
caused
by
excessive
such
as
apoptosis,
autophagy,
senescence,
ferroptosis,
have
studied.
Recovery
requires
integrity
cell
barrier
realization
gas
exchange
function.
Regeneration
include
participation
progenitor
various
niche
involving
several
signaling
pathways
proteins.
While
alveoli
are
damaged,
type
II
(AT2)
proliferate
differentiate
into
I
(AT1)
to
repair
damaged
layer.
Alveolar
surrounded
cells,
fibroblasts,
endothelial
immune
which
affect
proliferation
differentiation
AT2
through
paracrine
during
regeneration.
Besides,
airway
also
contribute
process
epithelium.
In
this
review,
we
mainly
discuss
transcription
factors.
MedComm,
Journal Year:
2024,
Volume and Issue:
5(2)
Published: Feb. 1, 2024
Abstract
Lung
tissue
has
a
certain
regenerative
ability
and
triggers
repair
procedures
after
injury.
Under
controllable
conditions,
lung
can
restore
normal
structure
function.
Disruptions
in
this
process
lead
to
respiratory
system
failure
even
death,
causing
substantial
medical
burden.
The
main
types
of
diseases
are
chronic
obstructive
pulmonary
disease
(COPD),
idiopathic
fibrosis
(IPF),
acute
distress
syndrome
(ARDS).
Multiple
cells,
such
as
epithelial
endothelial
fibroblasts,
immune
involved
regulating
the
Although
mechanism
that
regulates
not
been
fully
elucidated,
clinical
trials
targeting
different
cells
signaling
pathways
have
achieved
some
therapeutic
effects
diseases.
In
review,
we
provide
an
overview
cell
type
regeneration
repair,
research
models,
summarize
molecular
mechanisms
regulation
fibrosis.
Moreover,
discuss
current
stem
therapy
pharmacological
strategies
for
COPD,
IPF,
ARDS
treatment.
This
review
provides
reference
further
on
cellular
regeneration,
drug
development,
trials.